Lipid-Polymer Conjugation

Need Custom Lipid-Polymer Conjugates? Let BOC Sciences Help

BOC Sciences can provide comprehensive lipid-polymer conjugate solutions based on clients' drug delivery requirements, payload design, and nanoparticle platform construction goals. Our strengths lie in highly controllable chemical design, precise polymer parameter tuning, a wide selection of functional groups, and integrated expertise covering lipid chemistry, polymer chemistry, and nanomedicine.

Lipid-Polymer Conjugates

• Versatile polymer compatibility: Choose from PEG, PCL, PLA, PLGA, PAE, and other hydrophilic/hydrophobic or biodegradable polymers.
• Customizable lipid structures: Including phospholipids, cholesterol, fatty acids, amphiphilic lipids, ionizable lipids, and more.
• Adjustable hydrophobic core/hydrophilic shell: Achieve optimized nanoparticle size, stability, and in vivo circulation.
• Applicable to various delivery systems: Such as mRNA liposomes, siRNA nanoparticles, small-molecule sustained-release carriers, etc.

Lipid-Polymer Hybrid Nanoparticles

• Core-shell structure tuning: Strong core with flexible lipid shell for excellent in vivo stability.
• High payload capacity: Suitable for hydrophobic drugs, proteins, nucleic acids, and other complex cargos.
• Targeted modification capability: Ligands such as HA, peptides, and sugars enhance tumor or cell-specific delivery.
• Modular design flexibility: Core-shell, inverted, or multilayered structures can be tailored to client specifications.

Polymer-Coated Liposomes

• Enhanced stability and anti-protein adsorption: Outer polymer reduces carrier fusion and drug leakage.
• Prolonged circulation half-life: Polymers like PEG, PVP, or PVA significantly extend liposome blood retention.
• High surface functionalization potential: Grafting of targeting ligands or stimuli-responsive groups (pH, redox, enzymatic).
• Suitable for mRNA, siRNA, and chemotherapy drug delivery.

Lipid-Block Polymers

• Controllable molecular weight and block composition: Supports precise lipid-to-polymer ratio design.
• Diverse self-assembled structures: Form different nanostructures based on hydrophilic-hydrophobic balance.
• Applicable to stimuli-responsive platforms: pH, temperature, or redox-sensitive functional units can be incorporated.
• Ideal for advanced delivery systems: Such as oncolytic drug delivery or smart nanoreactor design.

Polymer-Grafted Lipids

• Precise grafting density control: From low-density to ultra-high-density brush structures.
• Modifies lipid bilayer flexibility and fluidity: Enhances membrane mechanical stability and permeability.
• Build "stealth" or highly hydrophilic nanoparticle surfaces: Improves circulation stability in blood.
• Adds controllable functional groups: Facilitates covalent modification with ligands, dyes, or sensor units.

Surface-Functionalized Lipid Nanoparticles

• Wide selection of functional groups: Including PEG, HA, RGD, peptides, sugars, and antibody fragments.
• Enhanced cell specificity and tissue targeting: For tumors, lymphatics, liver, or immune cells.
• Supports various stimuli-responsive ligands: pH, enzymatic, or temperature-triggered delivery.
• Suitable for high-precision mRNA delivery platforms: Meeting the latest design requirements in nucleic acid therapeutics.

Custom Lipid-Polymer Conjugation? We Make It Easy

BOC Sciences provides systematic lipid-polymer conjugation development services to the global drug R&D, nucleic acid therapy, biomaterials, and nanomedicine communities. Our advantages include not only structurally controlled conjugate design but also nanoparticle platform optimization, analytical quality systems, and full capabilities from R&D to small-scale scale-up.

Lipid Molecule Design and Custom Synthesis

• Support diverse structures including phospholipids, cholesterol derivatives, fatty acids, amphiphilic lipids, and cationic/ionizable lipids.
• Precise structural control of alkyl chain length, saturation, functional group position, and head group architecture.
• Introduce reactive groups such as carboxyl, amino, azide, alkyne, thiol, and maleimide for subsequent conjugation.
• Enable complex structures: branched lipids, multi-head lipids, block lipids, and biodegradable lipids.

Polymer Selection, Modification, and Customization

• Extensive library including PEG, PLGA, PLA, PCL, PAE, PEI, polysaccharides, and stimuli-responsive polymers.
• Control polymerization to adjust degree of polymerization, PDI, hydrophilic-lipophilic balance, and chain-end activity.
• Functionalized end groups available: NHS, COOH, NH2, SH, Azide, Maleimide.
• Special polymer platforms supported: brush polymers, block copolymers, multi-arm polymers, environment-responsive polymers.

Lipid-Polymer Covalent Conjugation Reactions

• Includes amidation, esterification, click chemistry (CuAAC/SPAAC), Michael addition, etc.
• Reaction conditions optimized for efficiency, yield, and purity.
• Product structure and bonding verified via GPC, NMR, LC–MS, FTIR.
• Ensures structural integrity of lipids and polymers throughout the reaction chain.

Lipid-Polymer Hybrid Nanoparticles Preparation

• Multiple preparation methods: nanoprecipitation, double emulsion, microfluidics, thin-film dispersion.
• Precise control of particle size, PDI, surface charge, core-shell structure, and lipid layer thickness.
• Formulations scalable for preclinical studies, ensuring in vivo stability, circulation time, targeting, and reproducibility.
• Optional ligand incorporation (HA, peptides, antibody fragments) or pH/enzyme-responsive modules.

Drug/Nucleic Acid Loading and Release Testing

• Suitable for small molecules, mRNA, siRNA, DNA, proteins, peptides.
• Optimal loading strategies tailored to molecular polarity, charge, and structure.
• Release evaluated under simulated physiological, pH gradient, or enzymatic conditions.
• Nanoplatform interactions assessed: stability, serum protein adsorption, cellular uptake, and transfection efficiency.

Quality Analysis and Scale-Up Production

• Multi-dimensional characterization via DLS, TEM, HPLC, LC–MS, GPC, NMR, ICP-MS.
• Customized purification strategies based on lipid/polymer types (dialysis, column chromatography, UF/DF).
• Scale-up from milligrams to multi-grams for early-stage or preclinical research.
• Strict control of particle size, surface chemistry, payload, and structural uniformity.

Technical Excellence and Service Benefits at BOC Sciences

• Full-stack lipid-polymer conjugation platform: From lipid design, polymer modification, covalent conjugation to hybrid nanoparticle construction, ensuring high controllability and consistency from molecule to nanosystem.
• Multidisciplinary professional R&D team: Polymer chemistry, lipid chemistry, nanomaterials, and drug delivery experts collaborate to provide scientific, efficient, and reliable technical solutions.
• Compatible with multiple reaction systems and complex structures: Supports esterification, amidation, click chemistry, Michael addition, and more, handling sensitive lipids and multifunctional polymers with high efficiency and integrity.
• Comprehensive analytical and quality control system: Equipped with DLS, GPC, LC–MS, NMR, TEM for structural identification, particle characterization, purity analysis, and stability studies to meet high-quality standards.
• Scalable nanoparticle preparation and production: Microfluidics, nanoprecipitation, and double-emulsion processes support linear scale-up from milligrams to grams, fulfilling exploratory to preclinical stage requirements.
• Flexible and responsive project management: One-on-one technical support, real-time progress updates, and plan adjustments ensure projects stay on schedule and goals are met.
• Safe, stable, industry-standard facilities: Labs and production platforms comply with GMP-level standards, with strict environmental control and material management to ensure batch consistency and safety.

How Our Lipid-Polymer Conjugation Services Work?

BOC Sciences provides end-to-end services from concept design to pilot-scale production, leveraging advanced lipid chemistry, polymer chemistry, and nanotechnology platforms to ensure every step is controllable, efficient, and aligned with both research and industrial needs. Our standard service workflow includes:

Project Requirement Discussion and Technical Evaluation

At the initial stage, we engage in in-depth discussions with clients to fully understand the carrier type, payload properties, targeting requirements, and application goals. A technical feasibility assessment is conducted based on project requirements, with preliminary proposals provided to guide subsequent design. This ensures that the R&D direction is closely aligned with client objectives.

Lipid and Polymer Design

Based on client application needs, we customize lipid molecules and polymer material plans, considering key parameters such as chain length, functional groups, block ratios, and molecular weight. Through molecular modeling and design optimization, the most suitable conjugation strategy is selected, ensuring material performance, structural stability, and functionalization potential, providing a solid foundation for nano-carrier development.

Small-Scale Development and Conjugation Optimization

During the laboratory-scale stage, covalent or non-covalent lipid-polymer conjugation experiments are performed to optimize reaction conditions, efficiency, and impurity control. Through iterative testing, solvent systems, temperature, molar ratios, and catalysts are adjusted to achieve high-purity, uniform conjugates, providing reliable samples for subsequent preparation and application.

Hybrid Nanoparticle Preparation and Self-Assembly Optimization

Conjugated lipid-polymer materials are formulated into hybrid nanoparticles, including micelles, vesicles, or core-shell structures. We optimize particle size distribution, surface charge, polymer shell thickness, and self-assembly conditions to ensure particle stability in vitro and in vivo, achieving the desired drug release profile and biocompatibility.

Loading Performance and In Vitro Characterization

Based on client requirements, small-molecule drugs, nucleic acids, proteins, or peptides are loaded into nanoparticles, followed by evaluation of loading efficiency, encapsulation rate, and release behavior. Serum stability, particle size variation, and functional assays are also performed, providing experimental data and optimization guidance for further applications.

Pilot-Scale Production and Final Delivery

After laboratory validation, pilot-scale production is carried out, with process optimization to ensure batch-to-batch consistency. Comprehensive quality analysis, stability studies, and technical documentation are provided, delivering high-quality lipid-polymer materials ready for further R&D or preclinical studies. Technical consultation and post-delivery support are also provided to ensure smooth project progression.

Explore the Applications of Lipid-Polymer Conjugates

Thanks to their highly controllable structures, excellent biocompatibility, and functionalization potential, lipid-polymer conjugates have been widely applied in drug delivery, gene therapy, immunomodulation, and regenerative medicine. BOC Sciences' lipid-polymer conjugation platform can design and construct efficient, stable nano-delivery systems tailored to diverse research and industrial needs.

mRNA Vaccines and Nucleic Acid Delivery

Lipid-polymer conjugated nanoparticles can effectively encapsulate mRNA, siRNA, DNA, and other nucleic acid therapeutics, protecting them from enzymatic degradation in vivo. By controlling lipid type, polymer chain length, and surface modification, nanoparticle circulation stability and cellular uptake are improved, enabling precise delivery to target tissues or cells and facilitating endosomal escape to ensure intracellular functionality.

Targeted Anti-Cancer Drug Delivery

Lipid-polymer hybrid nanoparticles can be used for tumor-targeted drug delivery. Surface modification with targeting ligands (such as HA, RGD peptides, or antibody fragments) enhances active targeting, increasing drug accumulation and efficacy at tumor sites. The polymer layer controls drug release rates, reduces off-target toxicity, and enhances therapeutic effectiveness and safety.

Gene Editing System Delivery

For CRISPR/Cas9, TALEN, or other gene-editing systems, lipid-polymer nanoparticles can stably encapsulate Cas9 mRNA or RNP complexes, ensuring efficient intracellular release. Optimized nanoparticle structures improve editing efficiency, reduce off-target effects, and enable cell-type-specific delivery, providing a reliable tool for gene therapy research.

Immunotherapy and Vaccine Adjuvant Development

Lipid-polymer conjugates can serve as vaccine adjuvants or immunomodulatory carriers. By tuning particle size, surface chemistry, and release kinetics, antigen delivery and immunogenicity are enhanced. Combining the membrane fusion capability of lipids with the stability of polymers allows sustained, targeted antigen release to immune cells, improving overall vaccine or immunotherapy efficacy.

Frequently Asked Questions

Still have questions?

Contact Us

• What is lipid–polymer conjugation?

  Lipid–polymer conjugation is the chemical linking of lipid molecules with polymers to form hybrid constructs. These conjugates combine the biocompatibility and structural properties of polymers with the membrane-interacting properties of lipids. They are widely used in drug delivery, gene therapy, and nanomedicine, enabling enhanced stability, targeted delivery, and controlled release of therapeutic agents.

• What types of polymers can be conjugated with lipids?

  A variety of polymers can be conjugated with lipids, including PEG, polycaprolactone, poly(lactic-co-glycolic acid), poly(amino acids), and biodegradable synthetic polymers. Selection depends on the intended application, solubility, and biocompatibility requirements. The conjugation can be precisely controlled to achieve desired molecular weight, hydrophilicity, and functional group density for optimal performance.

• How is lipid–polymer conjugation achieved?

  Lipid–polymer conjugation is typically performed using covalent chemistry, such as esterification, amidation, click chemistry, or Michael addition. The reaction conditions are carefully optimized to preserve functional groups on both lipid and polymer. Site-specific or controlled conjugation ensures reproducible molecular structures, essential for consistent performance in drug delivery systems and nanocarrier applications.

• What are the main applications of lipid–polymer conjugates?

  Lipid–polymer conjugates are widely used for mRNA and nucleic acid delivery, targeted cancer therapeutics, gene editing systems, and vaccine adjuvants. They also serve in tissue engineering and regenerative medicine. By improving particle stability, cellular uptake, and circulation time, these conjugates enhance therapeutic efficacy while reducing off-target effects.

• Can lipid–polymer conjugates improve drug delivery efficiency?

  Yes, lipid–polymer conjugates enhance drug delivery by improving nanoparticle stability, controlling drug release, and enabling targeted delivery to specific cells or tissues. Their amphiphilic structure facilitates interaction with biological membranes and improves encapsulation efficiency. This allows higher therapeutic payloads, reduced systemic toxicity, and improved bioavailability for a wide range of drugs and biomolecules.

• How customizable are lipid–polymer conjugates?

  Lipid–polymer conjugates are highly customizable. Parameters such as lipid type, polymer length, conjugation ratio, and functional modifications can be adjusted to meet specific project requirements. This flexibility allows optimization of pharmacokinetics, targeting properties, and therapeutic loading, making them suitable for diverse applications in pharmaceutical research, nanomedicine, and biomedical engineering.

• Are lipid–polymer conjugates biocompatible and safe?

  Lipid–polymer conjugates are designed for high biocompatibility, using lipids and polymers approved for biomedical use. Their biodegradability, non-immunogenic properties, and controlled degradation minimize toxicity risks. Safety depends on the specific combination and application, and rigorous in vitro and in vivo testing is recommended to ensure suitability for therapeutic or clinical applications.

Case Studies and Success Stories

Publications

This section showcases academic publications from international research teams using BOC Sciences' products and services, highlighting our industry impact in lipid supply and R&D.

• An advanced TALSPEAK concept for separating minor actinides. Part 2. Flowsheet test with actinide-spiked simulant. Solvent Extraction and Ion Exchange 35.6 (2017): 396-407. DOI: 10.1080/07366299.2017.1368945.
• Development and validation of rapid and simultaneous method for determination of 12 hair-growth compounds in adulterated products by UHPLC–MS/MS. Forensic science international 284 (2018): 129-135. PMID: 29408720 DOI: 10.1016/j.forsciint.2017.12.042.
• Cuban Policosanol (Raydel®) Exerts Higher Antioxidant and Anti-Glycation Activities than Chinese Policosanol (BOC Sciences) in Reconstituted High-Density Lipoproteins: In Vivo Anti-Inflammatory Activities in Zebrafish and Its Embryos. Pharmaceuticals 17.4 (2024): 406. DOI: 10.3390/ph17040406.
• Hopanoids, like sterols, modulate dynamics, compaction, phase segregation and permeability of membranes. Biochimica et Biophysica Acta (BBA)-Biomembranes (2019): 183060. DOI: 10.1016/j.bbamem.2019.183060.
• The long-chain monounsaturated cetoleic acid improves the efficiency of the n-3 fatty acid metabolic pathway in Atlantic salmon and human HepG2 cells. Br J Nutr. 2019; 122(7): 755-768. DOI: 10.1017/S0007114519001478.

Client Testimonials

Industry Distribution of Custom Lipid Synthesis Clients

"Working on a challenging mRNA delivery project, we needed custom lipid-polymer conjugates with precise polymer chain lengths and functionalization. BOC Sciences provided well-characterized materials and excellent technical guidance, enabling us to achieve high transfection efficiency."

— Dr. Emily Johnson, Senior Research Scientist (USA)

"Our gene editing studies required stable lipid-polymer hybrid nanoparticles for Cas9 RNP delivery. BOC Sciences delivered highly uniform conjugates and supported us with detailed characterization data. Their responsiveness and expertise were outstanding."

— Prof. Michael Schmidt, Molecular Biology Lead (Germany)

"Facing strict project timelines for a targeted chemotherapy nanoparticle, BOC Sciences designed and synthesized functionalized lipid-polymer conjugates that met our specifications. Their quality control and reproducibility were impressive."

— Dr. Claire Thompson, Formulation Scientist (UK)

"For our vaccine delivery platform, we needed lipid-polymer conjugates capable of high mRNA loading and serum stability. BOC Sciences not only provided optimized materials but also advised on nanoparticle formulation strategies, significantly accelerating our development."

— Dr. Antoine Dubois, Immunology Research Scientist (France)